VTE treatment EINSTEIN Jr Phase 3, noninferiority, open label, RCT Acute VTE treatment and secondary prevention Children ≤17 y with acute VTE N=500 Rivaroxaban (n=335) vs SoC (n=165) Treatment period: 3 mo (1 mo for children <2 y with CVC-associated VTE) Published DIVERSITY Phase 2b/3 noninferiority, open label, RCT Acute VTE treatment and secondary prevention Children <18 y with acute VTE N=267 Dabigatran (n=177) vs SoC (n=90) Treatment period: 3 mo followed by 1-mo observation period...